Jubilant Pharmova Limited (NSE:JUBLPHARMA)
India · Delayed Price · Currency is INR 1,090.00
-28.40 (-2.54%)
Oct 31, 2025, 3:30 PM IST
Jubilant Pharmova Market Cap
Jubilant Pharmova has a market cap or net worth of 173.85 billion as of October 31, 2025. Its market cap has decreased by -4.54% in one year.
Market Cap
173.85B
Enterprise Value
196.25B
Revenue
76.18B
Ranking
n/a
PE Ratio
36.39
Stock Price
1,090.00
Market Cap Chart
Since May 30, 2000, Jubilant Pharmova's market cap has increased from 406.73M to 173.85B, an increase of 42,642.83%. That is a compound annual growth rate of 26.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 173.85B | -0.61% |
| Dec 31, 2024 | 174.91B | 101.48% |
| Dec 29, 2023 | 86.81B | 45.28% |
| Dec 30, 2022 | 59.75B | -36.05% |
| Dec 31, 2021 | 93.44B | -30.56% |
| Dec 31, 2020 | 134.55B | 57.39% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.06T |
| Divi's Laboratories | 1.79T |
| Cipla | 1.21T |
| Apollo Hospitals Enterprise | 1.10T |
| Mankind Pharma | 984.02B |
| Zydus Lifesciences | 980.52B |
| Fortis Healthcare | 772.36B |
| Aurobindo Pharma | 661.47B |